| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1328048
[patent_doc_number] => 06599912
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Methods and compositions for modulating cell proliferation and cell death'
[patent_app_type] => B1
[patent_app_number] => 09/587559
[patent_app_country] => US
[patent_app_date] => 2000-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 43765
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599912.pdf
[firstpage_image] =>[orig_patent_app_number] => 09587559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/587559 | Methods and compositions for modulating cell proliferation and cell death | Jun 4, 2000 | Issued |
Array
(
[id] => 1096748
[patent_doc_number] => 06822083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'TSA305 gene'
[patent_app_type] => B1
[patent_app_number] => 09/555367
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10459
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/822/06822083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555367
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555367 | TSA305 gene | May 29, 2000 | Issued |
Array
(
[id] => 1014809
[patent_doc_number] => 06894153
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-17
[patent_title] => 'Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells'
[patent_app_type] => utility
[patent_app_number] => 09/674436
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 18367
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/894/06894153.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674436 | Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells | May 25, 2000 | Issued |
Array
(
[id] => 1115164
[patent_doc_number] => 06800436
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-05
[patent_title] => 'Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in LKB1 gene'
[patent_app_type] => B1
[patent_app_number] => 09/555166
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 18127
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800436.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555166 | Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in LKB1 gene | May 24, 2000 | Issued |
| 09/576455 | 46745, a novel human acyltransferase family member and uses thereof | May 22, 2000 | Abandoned |
Array
(
[id] => 1151270
[patent_doc_number] => 06767720
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-27
[patent_title] => 'CDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation'
[patent_app_type] => B1
[patent_app_number] => 09/574779
[patent_app_country] => US
[patent_app_date] => 2000-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 30
[patent_no_of_words] => 36600
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/767/06767720.pdf
[firstpage_image] =>[orig_patent_app_number] => 09574779
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/574779 | CDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation | May 18, 2000 | Issued |
Array
(
[id] => 529342
[patent_doc_number] => 07179588
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-02-20
[patent_title] => 'Assay for the detection of paclitaxel resistant cells in human tumors'
[patent_app_type] => utility
[patent_app_number] => 09/574099
[patent_app_country] => US
[patent_app_date] => 2000-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24479
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179588.pdf
[firstpage_image] =>[orig_patent_app_number] => 09574099
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/574099 | Assay for the detection of paclitaxel resistant cells in human tumors | May 17, 2000 | Issued |
Array
(
[id] => 1365380
[patent_doc_number] => 06566084
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Catalytic antibodies against cocaine and methods of using and producing same'
[patent_app_type] => B1
[patent_app_number] => 09/567021
[patent_app_country] => US
[patent_app_date] => 2000-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19441
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566084.pdf
[firstpage_image] =>[orig_patent_app_number] => 09567021
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/567021 | Catalytic antibodies against cocaine and methods of using and producing same | May 8, 2000 | Issued |
| 09/565714 | Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy | May 4, 2000 | Abandoned |
Array
(
[id] => 626928
[patent_doc_number] => 07135311
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-11-14
[patent_title] => 'Means for detecting and treating pathologies linked to FGFR3'
[patent_app_type] => utility
[patent_app_number] => 09/959747
[patent_app_country] => US
[patent_app_date] => 2000-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 4829
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/135/07135311.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959747
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959747 | Means for detecting and treating pathologies linked to FGFR3 | May 3, 2000 | Issued |
Array
(
[id] => 1362214
[patent_doc_number] => 06565870
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Methods for treating bone tumors'
[patent_app_type] => B1
[patent_app_number] => 09/561106
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9098
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/565/06565870.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561106
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561106 | Methods for treating bone tumors | Apr 27, 2000 | Issued |
Array
(
[id] => 948945
[patent_doc_number] => 06962981
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-11-08
[patent_title] => 'Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen'
[patent_app_type] => utility
[patent_app_number] => 09/561502
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 25
[patent_no_of_words] => 16316
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/962/06962981.pdf
[firstpage_image] =>[orig_patent_app_number] => 09561502
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/561502 | Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen | Apr 27, 2000 | Issued |
Array
(
[id] => 449160
[patent_doc_number] => 07250488
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-31
[patent_title] => 'Transcriptional activation inhibitory protein'
[patent_app_type] => utility
[patent_app_number] => 09/959474
[patent_app_country] => US
[patent_app_date] => 2000-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 20118
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/250/07250488.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959474
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959474 | Transcriptional activation inhibitory protein | Apr 25, 2000 | Issued |
| 09/553533 | Therapeutic compositions and methods for treating tumors | Apr 19, 2000 | Abandoned |
Array
(
[id] => 744958
[patent_doc_number] => 07026281
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-11
[patent_title] => 'Antagonistic analogs of GH-RH inhibiting IGF-I and -II'
[patent_app_type] => utility
[patent_app_number] => 09/547215
[patent_app_country] => US
[patent_app_date] => 2000-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11855
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026281.pdf
[firstpage_image] =>[orig_patent_app_number] => 09547215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/547215 | Antagonistic analogs of GH-RH inhibiting IGF-I and -II | Apr 10, 2000 | Issued |
Array
(
[id] => 486360
[patent_doc_number] => 07217735
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-15
[patent_title] => 'Methods and compositions for enhancing delivery of therapeutic agents to tissues'
[patent_app_type] => utility
[patent_app_number] => 09/547825
[patent_app_country] => US
[patent_app_date] => 2000-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22186
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217735.pdf
[firstpage_image] =>[orig_patent_app_number] => 09547825
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/547825 | Methods and compositions for enhancing delivery of therapeutic agents to tissues | Apr 6, 2000 | Issued |
Array
(
[id] => 1199375
[patent_doc_number] => 06723322
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-20
[patent_title] => 'Angiogenic Onchocerca volvulus proteins and uses thereof'
[patent_app_type] => B1
[patent_app_number] => 09/541759
[patent_app_country] => US
[patent_app_date] => 2000-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10825
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/723/06723322.pdf
[firstpage_image] =>[orig_patent_app_number] => 09541759
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/541759 | Angiogenic Onchocerca volvulus proteins and uses thereof | Apr 2, 2000 | Issued |
| 09/509775 | GANKYRIN | Mar 30, 2000 | Abandoned |
Array
(
[id] => 1275429
[patent_doc_number] => 06649743
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-18
[patent_title] => 'Monoclonal antibody against estrogen stimulated leucine aminopeptidase'
[patent_app_type] => B1
[patent_app_number] => 09/538831
[patent_app_country] => US
[patent_app_date] => 2000-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8202
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/649/06649743.pdf
[firstpage_image] =>[orig_patent_app_number] => 09538831
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/538831 | Monoclonal antibody against estrogen stimulated leucine aminopeptidase | Mar 29, 2000 | Issued |
| 09/536087 | THROMBOSPONDIN-2 AND USES THEREOF | Mar 23, 2000 | Abandoned |